World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
66
Citations
12834
World Ranking
2444
National Ranking
85

Janaki Amin publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Janaki Amin sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 236 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Janaki Amin D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Janaki Amin sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 66 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Janaki Amin is affiliated with Macquarie University in Australia and has contributed extensively to the field of medicine, focusing primarily on epidemiology, infectious diseases, hepatology, general health professions, and oncology. Their research output includes 152 publications in medicine, with significant work in epidemiology (64 publications), infectious diseases (25), and hepatology (25).

Amin's research topics cover a range of issues including HIV, drug use, sexual risk, hepatitis C virus research, HIV/AIDS research and interventions, hepatitis B virus studies, liver disease diagnosis and treatment, child and adolescent health, and sex work and related issues. These focus areas are reflected in Amin's numerous scientific contributions.

The researcher has frequently published in the following venues:

  • Clinical Infectious Diseases
  • Journal of Hepatology
  • International Journal of Environmental Research and Public Health
  • International Journal of Drug Policy
  • JHEP Reports

Janaki Amin has collaborated frequently with several coauthors, notably:

  • Gregory J. Dore
  • Jason Grebely
  • Behzad Hajarizadeh
  • Phillip Read
  • Carla Treloar

Among Amin's recent papers are:

  • Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study (2021, The Lancet HIV)
  • Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study (2021, The Lancet. Gastroenterology & Hepatology)
  • Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study (2020, Clinical Infectious Diseases)
  • Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis (2021, New England Journal of Medicine)
  • Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men (2020, JAMA Network Open)

In addition to journal publications, Amin has contributed to book publications with one title published by Verlag Barbara Budrich, titled Early Childhood Education Leadership in Times of Crisis (2023).

Best Publications

  • Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression

    Reem Waziry;Behzad Hajarizadeh;Jason Grebely;Janaki Amin

  • The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

    Jason Grebely;Kimberly A Page;Rachel Sacks-Davis;Martin Schim van der Loeff

  • Life expectancy of HIV‐positive people after starting combination antiretroviral therapy: a meta‐analysis

    S Teeraananchai;SJ Kerr;SJ Kerr;J Amin;K Ruxrungtham

  • Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population.

    Alison J. Rodger;Rebecca Lodwick;Mauro Schechter;Steven Deeks

  • Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.

    Andrew Carr;Cassy Workman;Don E. Smith;Jennifer Hoy

  • Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.

    Allison Martin;Don E Smith;Andrew Carr;Clare Ringland

  • Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.

    Andrew E. Grulich;Rebecca Guy;Janaki Amin;Fengyi Jin

  • Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study

    Janaki Amin;Matthew G Law;Mark Bartlett;John M Kaldor

  • Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.

    Jason Grebely;Olav Dalgard;Brian Conway;Evan B Cunningham

  • Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial

    Allison Martin;Mark Bloch;Janaki Amin;David Baker

  • The pattern of excess cancer in dialysis and transplantation

    John H. Stewart;Claire M. Vajdic;Marina T. van Leeuwen;Janaki Amin

  • Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial.

    Rebekah L. Puls;Janaki Amin;Marcelo Losso;Praphan Phanuphak

  • Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study

    Janaki Amin;Gregory J. Dore;Dianne L. O’Connell;Mark Bartlett

  • Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study

    Marina T van Leeuwen;Angela C Webster;Margaret R E McCredie;John H Stewart

  • HIV and hepatitis C coinfection within the CAESAR study.

    J Amin;M Kaye;S Skidmore;D Pillay

  • A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand

    Gail V. Matthews;Anchalee Avihingsanon;Sharon R. Lewin;Sharon R. Lewin;Janaki Amin

  • Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study

    Jason Grebely;Francois M J Lamoury;Behzad Hajarizadeh;Yasmin Mowat

  • Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation.

    Marina T. van Leeuwen;Andrew E. Grulich;Angela C. Webster;Margaret R.E. McCredie

  • Quantifying the dose-response of walking in reducing coronary heart disease risk: meta-analysis.

    Henry Zheng;Nicola Orsini;Janaki Amin;Alicja Wolk

  • Measurement of Serum Levels of Macrophage Inhibitory Cytokine 1 Combined with Prostate-Specific Antigen Improves Prostate Cancer Diagnosis

    David A. Brown;Carsten Stephan;Robyn L. Ward;Mathew Law

Frequent Co-Authors

Gregory J. Dore
Gregory J. Dore University of New South Wales
Jason Grebely
Jason Grebely University of New South Wales
David A. Cooper
David A. Cooper University of New South Wales
Matthew Law
Matthew Law University of New South Wales
Sean Emery
Sean Emery University of New South Wales
Anthony D. Kelleher
Anthony D. Kelleher University of New South Wales
Andrew E. Grulich
Andrew E. Grulich University of New South Wales
Andrew Carr
Andrew Carr University of Oxford
Margaret Hellard
Margaret Hellard Burnet Institute
Gail V. Matthews
Gail V. Matthews University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens the door to various related online degrees that can broaden your career options. For individuals with unique challenges, there are programs tailored to diverse needs, including those exploring what can a felon go to college for. This ensures education is accessible to a wider community.

Many graduates consider combining their science background with healthcare by pursuing functional medicine nurse practitioner programs. These allow professionals to offer holistic patient care grounded in both traditional and innovative medical knowledge.

Other viable career paths linked to microbiology include medical coding and health information management. Becoming a certified professional coder is a promising avenue for those interested in medical data and billing, while earning a master in health information management salary can lead to senior roles in healthcare administration.

Exploring these pathways can help microbiology students find unique niches that match their skills and interests in the evolving healthcare landscape.

Best Scientists Citing Janaki Amin

Trending Scientists

Recently Published Articles